Background/Aims: Diabetic retinopathy (DR) is one of the main causes of blindness in the world. Our previous study showed that transthyretin (TTR) regulates key genes in the Tie2 pathway and inhibits the development of neovascularization in DR, but the mechanism is still unclear. Here, we investigated how TTR affects the progression of neovascularization in DR. Methods: Natural and simulated DR media (hyperglycemia and hypoxia) were used to culture human retinal microvascular endothelial cells (hRECs). Flow cytometry was employed to investigate the effect of TTR on apoptosis of hRECs. Fluorescent labeling and immunofluorescence staining were used to determine the TTR distribution in hRECs. The membrane proteins of hRECs were extracted and applied to a sepharose-TTR column, and the captured proteins were identified by Mass Spectrometric analysis. Gene knock-down and western blotting assays were used to study the key signal pathway of the most abundant identified protein. Results: TTR induced apoptosis of hRECs in an environment that simulated hypoxia. Immunofluorescent staining showed that TTR could enter the nuclei of hRECs. A total of 30 unique TTR-captured proteins were identified by Mass Spectrometry, and glucoseregulated protein 78 (GRP78) was one of the most abundant. Western blotting and gene knock-down indicated that TTR might upregulate GRP78 and facilitate apoptosis through the eIF2α/CHOP pathway. Conclusions: In the DR environment (hyperglycemia and hypoxia), TTR was shown to repress neovascularization by promoting apoptosis of hRECs through a GRP78-dependent pathway.
Transthyretin Exerts Pro-Apoptotic Effects in Human Retinal Microvascular Endothelial Cells Through a GRP78-Dependent Pathway in Diabetic Retinopathy
Jun
Introduction
Diabetic retinopathy (DR) is one of the most serious diabetic microangiopathic complications and is one of leading cause of blindness in the world [1] . An epidemiological survey showed that the prevalence rate of DR in China has increased on a yearly basis [2] . DR is caused by alterations in the retinal micro vasculature in diabetic patients, and retina neovascularization is one of the most significant clinical properties of proliferative diabetic retinopathy (PDR) [3] . Therefore, anti-neovascularization strategies are the only effective form of therapy for PDR. However, this therapeutic strategy cannot fundamentally reverse the patient's permanently damaged vision. Thus, optimized methods are urgently needed to investigate detailed mechanisms of DR and to deliver potent treatments against DR [4] . Recently, some new mechanisms have been reported in the development of DR, including protein palmitoylation [5] and autophagy [6] . In addition, several compounds and potential targets have been proven to attenuate neovascularization and retinal vascular leakage through specific pathways [7, 8] . A previous report indicated that retinal hypoxia is a major component of the pathophysiology in the advanced, sight-threatening stages of DR [9] . Under hypoxic conditions, hypoxiainducible factor-1α (HIF-1α) is activated and stabilized. This factor regulates hypoxiainducible genes including VEGFA which is involved in the angiogenic response, as well as erythropoiesis factor (e.g., EPO) [10] [11] [12] . Thus, physiological and pathological research on hRECs in a hypoxic environment is helpful in understanding the development of DR.
Transthyretin (TTR) is a 55-kDa homotetrameric protein that is found in the plasma and cerebrospinal fluid. This protein is synthesized in the liver (blood source) and choroid plexus (cerebrospinal fluid source). It is also produced by human retinal pigment epithelial cells (hRPECs) in ocular tissue [13] . The physiological functions of TTR are to transport thyroxine and retinol through retinol-binding protein (RBP). In ophthalmology research, various eye diseases are associated with TTR. Nuclear cataracts are associated with low protein intake and low serum levels of TTR [14] . Immunohistochemical analysis of the drusen in patients with age-related macular degeneration revealed the presence of TTR [15] . In our previous study, patients with macular detachment (MD) and macular holes (MH) demonstrated complete or partial losses of the natural bio-functions of the vitreous TTR. However, these losses appeared to be associated with abnormally high TTR levels [16] . The TTR in the MD vitreous compartment had an abnormally stable tetrameric structure, possibly due to misfolding [17] . In our recent studies, we found that the key genes in Tie2 pathway for DR neovascularization, including Tie2 (tyrosine-protein kinase receptor 2), VEGFR1 (vascular endothelial growth factor receptor 1), VEGFR2 (vascular endothelial growth factor receptor 2), Angpt1 (Angiopoietin 1) and Angpt2 (Angiopoietin 2), were regulated by TTR [18, 19] . TTR represses neovascularization in DR, but the mechanisms by which TTR affects the development of neovascularization in DR remains unclear.
In the present study, we elucidated the molecular pathways that involved TTR under DR, during both physiologic and pathologic conditions. Proteomic assays were used to investigate the specific mechanisms by which TTR efficiently inhibits neovascularization in DR. Membrane proteins were applied to an immobilized-TTR column and the TTRcaptured proteins were identified with LTQ-MS analysis. GRP78 was identified as the key hub stimulated by TTR, and the correlated interaction clusters were investigated herein. Our study revealed that TTR promotes apoptosis of hRECs via a GRP78-dependent pathway in simulated DR environments.
Materials and Methods

Reagents and cell culture
This study followed the tenets of the Declaration of Helsinki and the ARVO statement for research involving human subjects and was approved by the Ethics Committee of Nanjing Medical University. The Expresso Rhamnose kit was purchased from Lucigen (Middleton, WI, 
Expression, preparation and labeling of TTR
The wild-type TTR was produced in an E. coli expression system from Lucigen (Middleton, WI, USA) and purified as described previously [20] . The human TTR cDNA was inserted into a pRham™ N-HIS vector, and the plasmid was used to transform E. coli BL21 (DE3). The E. coli BL21 (DE3) cells containing the plasmid were grown overnight in 5 mL LB broth with 50 μg/ mL ampicillin at 37 °C and 200 rpm. A flask containing 500 mL of culture medium (LB broth with ampicillin) was inoculated with 5 mL of the starter cultures at 37 °C and 200 rpm until the A 600 nm reached 0.6. The expression of TTR was then induced with 0.2% rhamnose for 5-6 h. The cells were collected by centrifugation at 4 °C and 8000 ×g for 30 min, and then the cell pellet was disrupted by sonication. After centrifugation at 4 °C and 8000 ×g for 30 min, the supernatant was applied to a Ni-Sepharose column, which was subsequently washed with washing buffer 1 (20 mM Tris-HCl, pH 8.0, 20 mM imidazole), washing buffer 2 (20 mM Tris-HCl, pH 8.0, 50 mM imidazole) and washing buffer 3 (20 mM Tris-HCl, pH 8.0, 100 mM imidazole). The captured TTR was finally eluted with elution buffer (20 mM Tris-HCl, pH 8.0, 400 mM imidazole). The imidazole was depleted by 6 cycles of ultrafiltration in an Amicon Ultra YM-3 tube (Merck Millipore). The endotoxin in the protein sample was depleted using a ToxinEraser TM Endotoxin Removal kit from GenScript. The resulting samples were subjected to SDS-PAGE analysis.
The only cysteine in TTR is located at the N-terminus, therefore, TTR could be site-specifically labeled at this cysteine with N-(5-Fluoresceinyl) maleimide as previously reported [21, 22] . The purified TTR was incubated with 5 mM DTT in 20 mM Tris-HCl (pH 8.0) at 4 °C for 2 h, and then, to remove the DTT, the protein was precipitated and washed with 75% (NH 4 ) 2 SO 4 at 4 °C. Then, the protein was reacted with N-(5-Fluoresceinyl) maleimide at 4 °C overnight at a ratio of 1:5. After this reaction, the free labeling reagent was removed by 6 cycles of ultrafiltration.
Culture of hRECs in natural and simulated DR environments
hRECs from passages 3-6 were cultured in 6-well plates using the following protocols. Low glucose, high glucose, and hypoxic media were prepared according to previous reports [18, 19] LG+Hypoxia and HG+Hypoxia) [23] [24] [25] .
Flow cytometric analysis hRECs from passage 4 were diluted to 8×10 4 /mL and incubated in 6-well plates with low glucose media for approximately 12 h until confluent. After washing with PBS, the cells were further cultured for 48 h at 37 °C in low glucose (LG), low glucose with hypoxia (LG+Hypoxia), high glucose (HG), or high glucose with hypoxia (HG+Hypoxia) media. Approximately 4 μmol/L TTR was included in the media according to a previously described protocol [18, 19] . The cells were trypsinized, collected, washed in PBS, and analyzed using a Dead Cell Apoptosis Kit (ThermoFisher Scientific). The cells were resuspended in 100 μL of binding buffer containing 5 μL Annexin V-FITC and 5 μL propidium iodide. The samples were mixed gently and incubated at room temperature in the dark for 20 min. An additional 500 μL binding buffer was then added to each sample tube, and the samples were analyzed using fluorescence-activated cell sorting (FACS) (BeckmanCoulter, Kraemer Boulevard Brea, CA, USA). A minimum of 10, 000 cells within the gated region were collected. All the tests were repeated three times.
Membrane protein extraction
The membrane proteins from hRECs (passage 5) were extracted using Mem-PER TM PLUS Kit. A total of 5×10 6 cells were resuspended in the growth media by scraping the cells off the surface of the plate with a cell scraper. The harvested cell suspension was centrifuged at 300 ×g for 5 min. The cell pellet was washed with 3 mL Cell Wash Solution and centrifuged at 300 ×g for 5 min, after which the supernatant was carefully removed and discarded. The cells were resuspended in 1.5 mL Cell Wash Solution, transferred to a 2 mL centrifuge tube and centrifuged at 300 ×g for 5 min. The supernatant was discarded, and 0.75 mL Permeabilization Buffer was added to the cell pellet. After vortexing briefly, the sample was incubated for 10 min at 4 °C with constant mixing, and then centrifuged for 15 min at 16, 000 ×g. The supernatant, which contained the cytosolic proteins, was carefully removed and transferred to a new tube. The pellet was resuspended in 0.5 mL Solubilization Buffer by trituration. The tubes were incubated at 4 °C for 30 min with constant mixing and then centrifuged at 16, 000 ×g for 15 min at 4 °C. The supernatant containing the solubilized membrane and membrane-associated proteins was transferred to a new tube. The resulting fractions were stored on ice or stored as aliquots at -80 °C for future use.
Screening for TTR-associated proteins
Recombinant human TTR was immobilized on CNBr-activated sepharose beads by combining 2 mg TTR with 1 mL beads in 0.1 M NaHCO 3 /0.5 M NaCl (pH 8.3). After mixing at 4 °C overnight, the beads were packed into a 1 mL column and equilibrated with 20 mM PBS containing 0.1% Triton X-100 (pH 7.2). The extracted membrane proteins were applied to the TTR-sepharose column, washed five times with 20 mM PBS/0.1 Triton X-100 (pH 7.2), and the proteins captured by TTR were eluted with 20 mM PBS/0.1 Triton X-100/0.5 M NaCl (pH 7.2).
The eluted proteins were analyzed using LTQ-MS. Briefly, 25 μg trypsin was dissolved in 2.5 mL tosylphenylalanylchloromethane (TCPK) mixed with 250 μL of 0.1% redistilled acetonitrile. A 15 μL sample of this trypsin solution was activated in 100 μL 50 mM NH 4 HCO 3 . A 5μL aliquot of the TTR-captured proteins was reduced with 100 μL of reducing buffer (200 μL TCEP in 2 mL digestion buffer (50 mM ammonium bicarbonate, pH 7.5)) and incubated at 60 °C for 10 min. Following this incubation, 100 μL of alkylation buffer (60 mg iodoacetamide in 3 mL digestion buffer) was added to the tube, and the mixture was incubated in the dark at room temperature for 1 h for carboxymethylation and oxidation of the cysteine and methionine residues. Then, 20 μL of the activated trypsin solution was Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry added to the tube and incubated at 37 °C for 1 h, followed by incubation at 25°C overnight with gentle mixing. This peptide mixture was injected onto a Zorbax300SB-C18 peptide trap (Agilent Technologies, Wilmington, DE, USA) for desalting, and separation was performed on a Zorbax 300SB-C18 reverse phase capillary column (300 μm inner diameter×15 cm; Agilent Technologies). The mobile phases were 0.1% formic acid (A), and 84% CH 3 CN with 0.1% formic acid (B). The flow rate was 500 nL/min with a linear gradient of 4-50% B over 50 min, an increase to 100% B over 4 min, then 100% B for 10 min. The peaks were injected online into a Finnigan LTQ (single linear quadrupole ion trap) mass spectrometer for peptide identification. Mass spectrometry was performed on a Finnigan LTQ linear ion trap. The mass spectrometry (MS) method consisted of a cycle combining one full MS scan with two MS/MS events (25% collision energy). The dynamic exclusion duration was set to 30 s.
Fluorescent localization of TTR and GRP78
hRECs from passage 5 were incubated under normal conditions for 24 h at 37 °C in 24-well plates, after which 4 μmol/L N-(5-Fluoresceinyl) maleimide-labeled TTR was added to the media, and the cells were incubated for 1-6 h longer. After this incubation, the wells were washed 6 times with the primary media, and the cells were then visualized using a fluorescence microscope (Olympus Corp, Tokyo, Japan).
After culturing hRECs (from passage 5) in normal media for 24 h at 37 °C, approximately 4 μmol/L TTR (unlabeled) was added for 6 h. The cells in wells were washed three times with PBS, fixed in 4% paraformaldehyde for 20 minutes, permeabilized in 0.1% Triton X-100, and exposed to the indicated primary antibodies overnight at 4 °C. After exposure to secondary antibodies and counterstaining with Hoechst33342, the cells were visualized using a fluorescence microscope (Olympus Corp, Tokyo, Japan).
Cell transfection and GRP78 RNAi assays hRECs (from passage 6) were transiently transfected with 100 nmol/L of GRP78 siRNA (Santa Cruz Biotechnology, Santa Cruz, CA,USA) using Lipofectamine-2000 reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer's protocol. After incubation for 24 h, hRECs were harvested for further experiments.
Western blotting hRECs were harvested from 6-well plates, and the protein was extracted from the cells using RIPA buffer with protease inhibitors. The protein concentration was measured using a BCA assay kit. Equal amounts of protein (15 μL of protein sample, ~2 mg/mL) were separated using 10% SDS-PAGE and transferred to a nitrocellulose membrane. After blocking with 5% non-fat-dried milk, the membrane was incubated with diluted primary antibodies overnight at room temperature (~25 °C), followed by incubation with the secondary antibody. Western blotting was performed using antibodies against GRP78, PERK, CHOP, ATF4, eIF2α and GAPDH. The quantitative densitometric values for each protein were normalized to GAPDH, and membranes were then scanned using an Odyssey Image System (LI-COR Biosciences, Lincoln, NE, USA). The band intensities were analyzed using Bio-Rad Quantity One software (version 4.4.0; Bio-Rad, Hercules, CA, USA) for quantification.
Statistical analysis SPSS 13.0 for windows (Chicago, IL, USA) was used for data analysis, and statistical significance was determined using a T test. The P and T values were calculated. P<0.05 was considered statistically significant.
Results
Production and fluorescent labeling of TTR
After the Ni-column separation, endotoxin depletion and fluorescent labeling, reducing SDS-PAGE analysis revealed a single band of the purified and tagged TTR below 20 kDa as the monomer (Fig. 1A) . Furthermore, on the basis of the optimal fluorescent signal of N-(5-
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Fluoresceinyl) maleimide (λ ex 492 nm; λ em 518 nm), the labeling ratio was calculated as ~95% (n=3) (Fig. 1B) .
TTR represses neovascularization in DR by inducing apoptosis
Our previous research showed that TTR inhibited the proliferation of hRECs and neovascularization [13, 14] . To evaluate whether the decrease in cell proliferation induced by TTR was apoptotic, flow cytometry was used to detect the presence of cell death. In simulated DR environments with high glucose and hypoxia, we found that apoptosis occurred in about 30 % of the cells treated with the combination of TTR and hypoxia, but apoptosis was not significantly different in the HG or normal environments (Fig. 2) . This suggested that TTR significantly enhanced the anti-angiogenic effect by inducing apoptosis under hypoxic conditions (LG+Hypoxia vs LG+Hypoxia+TTR, p= 0.002, T= -24.844; HG+Hypoxia vs HG+Hypoxia+TTR, p= 0.002, T= -24.512).
TTR affects hRECs by passing through the cell membrane to the nucleus
According to the fluorescent signal of N-(5-Fluoresceinyl) maleimide tag that remained in the cells, TTR could enter hRECs within 6 h (Fig. 3A) .
To investigate the exact location of the TTR in the hRECs, after incubation with TTR for 6 h, the coverslips were sequentially incubated with mouse anti-human TTR antibody and with Alexa Flour 488-conjugated donkey anti-mouse IgG secondary antibody. In the subsequent fluorescent analysis, a higher magnification of a same nucleus (marked with arrow) is shown in the upper right corner of each figure (Fig. 3) . The nuclei were stained with Hoechst 33342 (Fig. 3B) , and the TTR remaining in cells was stained with Alexa Flour 488 (Fig. 3C) . The TTR region generally overlapped with nucleus (Fig. 3D) . This revealed that TTR could efficiently cross the cell membrane and nuclear membrane.
Identification of TTR-interacting proteins on membrane structures
The TTR-captured membrane proteins were identified by LTQ-MS analysis. The MS/MS spectra acquired from all the runs were searched against the IPI HUMAN v3.87 database using the program SEQUEST. The SEQUEST filter was set to Xcorr≥1.9 for Charge +1, Xcorr≥2.2 for Charge +2, Xcorr≥3.75 for Charge +3, and DelCN≥0.1. Thirty unique proteins with more than four peptides and more than 15% CoverPercent were identified (Table 2 ). GRP78 was one of the most abundant of the TTR-captured proteins. 
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TTR upregulates GRP78 and triggers cell transition from ER stress to apoptosis through EIF2α/CHOP pathway
To further examine the relationship between TTR and GRP78, the GRP78 contents were evaluated using western blotting assays. Consistent with LTQ-MS data, we observed a noticeable upregulation of GRP78 in the cells that had been treated with TTR combined with hypoxia (Fig. 4A , in Line GRP78, Lane 3 vs 4 and Lane 7 vs 8).
Eukaryotic translationinitiation factor alpha (eIF2α), protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating transcription factor-4 (ATF4) have been reported to constitute the essential pathway underlying the unfolded protein response (UPR) [26] [27] [28] . These proteins are closely associated with GRP78 signaling pathways. In western blots (Fig. 4A) these results suggested that TTR caused an upregulation of GRP78 in hypoxia, which led to the progression from ER stress to apoptosis through eIF2α/CHOP pathway.
GRP78 siRNA partially reverses TTR-induced apoptosis in hRECs
For the rescue experiments, the viability of hRECs that had been transfected with GRP78 siRNA was investigated. GRP78 siRNA partially reversed the TTR-induced apoptosis of hRECs in the simulated DR environments (Fig. 5) . The expression of GRP78 after the transient transfection of siRNA is decreased (Fig. 4A and B , in Line GRP78). To investigate whether the downregulation of PERK, eIF2α, ATF4 and CHOP was dependent on GRP78, expression of these proteins was compared in TTR/ low glucose/high glucose/CoCl 2 -treated cells with and without GRP78 siRNA. In the cells treated with the RNAi, the expression levels of PERK (Fig.  4 A and B , in Line PERK), eIF2α (Fig. 4 A and B , in Line eIF2α), ATF4 (Fig. 4 A and B , in Line ATF4) and CHOP (Fig. 4 A and B , in Line CHOP) revealed reduced trends. Taken together, our results revealed that TTR facilitated apoptosis through a GRP78-dependent pathway.
Discussion
TTR is mainly secreted by the hRPECs and choroid in the eyes; ocular diseases such as high myopia and vitreous amyloidosis are associated with alterations in the structure or function of TTR [29, 30] . Our previous study showed that only in a high glucose environment, but independent of hypoxia, could TTR (exogenous and endogenous) repress the proliferation, migration and tube formation by regulating the key genes in the Tie2 pathway [18] . In this study, we found that TTR significantly induced apoptosis in hypoxic environments, regardless of hyperglycemia. These phenomena suggested that, in the DR environment, hypoxia was necessary for the TTR-mediated apoptosis of the hRECs, whereas hyperglycemia was required for TTR to inhibit the hRECs proliferation.
A group of TTR-captured membrane proteins were identified with LTQ-MS analysis, and GRP78 was revealed to be one of the most abundant. GRP78 (BiP) is a 78-kDa protein chaperone [26, 27] that has been proven to prevent the cell death caused by disturbance of endoplasmic reticulum (ER) homeostasis [28] and to mediate essential components of ER stress-induced apoptosis [31] [32] [33] . Fluorescent labeling and immunofluorescence staining indicated that TTR efficiently crossed cell membrane and nuclear membrane; the localization of TTR and GRP78 partially overlapped in and around the nuclei. In rescue experiments, GRP78 siRNA partially prevented the TTR-induced apoptosis. These results suggested that there might be a direct interaction between TTR and GRP78. Furthermore, in the hypoxic DR environment, TTR might target GRP78 to trigger cell apoptosis. Here, our results show for the first time that TTR upregulates GRP78 to control cell apoptosis.
The ER is the major organelle responsible for protein folding, lipid biosynthesis and Ca 2+ storage. Recent studies have established that the ER also functions as an intracellular signaling platform that regulates cell fate and activity through the unfolded protein response (UPR) [34] . With ER stress, three ER transmembrane proteins activate the UPR: PERK, ATF4 and eIF2α. These UPR branches coordinate the regulation of protein translation and transcription programs to restore ER homeostasis [35] . Unresolved ER stress activates proapoptotic and proinflammatory genes, such as those encoding CHOP, which contributes to retinal inflammation and vascular dysfunction in ischemic retinopathy and DR [36] . In endothelial cells, activation of the UPR plays a critical role in regulating cell proliferation, apoptosis and angiogenesis [37] , and in this pathway, CHOP is a well-characterized marker for the cell transition from ER stress to apoptosis [38, 39] . Recent research has provided the first investigation of a role for ER stress in the dysfunction of angiogenic progenitors in diabetes, and the GRP78-mediated pathway is the key step [40] . In our research, we observed that TTR meaningfully increased CHOP and enhanced the expression of eIF2α, PERK and ATF4. Together, these data suggested that TTR might cause ER stress and eventually trigger the cell transition from ER stress to apoptosis. 
Conclusion
In a DR environment with hypoxia, TTR could induce the apoptosis of hRECs through a GRP78-dependent pathway by regulating the expression of GRP78, eIF2α, PERK, ATF4 and CHOP. On the other hand, according to our previous work [18] , hyperglycemia in the DR environment should be necessary for TTR to inhibit the proliferation, migration and tube formation of hRECs by affecting the Tie2 pathway. However, the details of these processes and the mechanisms by which TTR could enter the nucleus are still not clear (Fig. 6) . To understand the mechanism of these phenomenon more thoroughly, future studies should consider performing gene chip analysis and target molecule screening analysis to integrate the whole pathway. For clinical applications, the serum and vitreous TTR levels in DR development will require systematic investigation, and these results may help to refine the grading and diagnosis of DR. In addition, for the prevention and therapy of DR, maintaining a relatively high TTR level in ocular tissue might be considered a possible future approach.
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